The purpose of the present project was to analyse and to characterize the metabolic profile of human breast cancer cell lines and plasma samples of TNBC from HBOC patients who were carriers and non‐carriers of germline mutations in the BRCA1 gene. The gene discussed is BRCA1; the disease is breast cancer.